Loss of RB and MTS1/CDKN2 (p16) expression in human sarcomas
Authors:
- Joseph GeradtsJGJoseph Geradts
- 1 August 1997
- journal article
- Published by Elsevier in Human Pathology
- Vol. 28 (8) , 893-898
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Role of the INK4a Locus in Tumor Suppression and Cell MortalityCell, 1996
- Alterations of the p15, p16, and p18 genes in osteosarcomaCancer Genetics and Cytogenetics, 1996
- Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomasBritish Journal of Cancer, 1995
- Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas - relationship to amplification and mRNA levels of CDK4 and CCND1British Journal of Cancer, 1995
- Cell-cycle regulators and cancerTrends in Genetics, 1995
- Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinomaNature Genetics, 1994
- Retinoblastoma protein monoclonal antibodies with novel characteristicsJournal of Immunological Methods, 1994
- Altered Expression of the Retinoblastoma Gene Product in Human SarcomasNew England Journal of Medicine, 1990
- Reproducibility of a histopathologic grading system for adult soft tissue sarcomaCancer, 1986
- Second primary neoplasms in patients with retinoblastomaBritish Journal of Cancer, 1986